Company: IOBT
Filing Date: 2025-07-24
Form Type: S-3
Source: 0001193125-25-164495
Chunk: 7

Company: IO Biotech, Inc.
Filing Date: 2025-07-24
Form: S-3
Chunk 7
---
IB Warrants and (ii) May 15, 2025 (the “Filing Deadline”), and to cause such registration statement to become effective within a specified period
after the Filing Deadline. The Company is also required to register the shares of Common Stock underlying the Tranche B Warrants and would be required to register the shares of Common Stock underlying the Tranche C Warrants, in either case, within
30 days following the issuance date of the applicable EIB Warrants.

The foregoing is only a summary of the terms of the Finance Contract, the Side
Letter, the Warrant Issuance Agreement, the Warrants, and the Registration Rights Agreement, does not purport to be complete and is qualified in its entirety by reference to the full text thereof, copies of each of which have previously been filed
as exhibits to our filings with the SEC.

Implications of Being an Emerging Growth Company and Smaller Reporting Company

The Jumpstart Our Business Startups Act (the JOBS Act) was enacted in April 2012 with the intention of encouraging capital formation in the United States and
reducing the regulatory burden on newly public companies that qualify as emerging growth companies. We are an “emerging growth company” within the meaning of the JOBS Act. We may take advantage of certain exemptions from various public
reporting requirements, including the requirement that we provide more than two years of audited consolidated financial statements and related management’s discussion and analysis of financial condition and results of operations, and that our
internal controls over financial reporting be audited by our independent registered public accounting firm pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act). In addition, the JOBS Act provides that an
“emerging growth company” can delay adopting new or revised accounting standards until those standards apply to private companies. We intend to take advantage of these exemptions until we are no longer an emerging growth company. We have
elected to use the extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (1) are no longer an emerging
growth company and (2) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our consolidated financial statements may not be comparable to companies that comply with new or revised
accounting pronouncements as of public company effective dates.

We will